Pipeline
FDA grants RMAT designation to 4DMT for DME gene therapy
4D-150 provides a multi-year sustained delivery of anti-VEGF from the retina via a single, low-dose IVT delivery—potentially reducing the need for frequent bolus injections.
Products
OcuSciences receives FDA clearance for retinal health assessment tool
The OcuMet Beacon, a confocal scanning ophthalmoscope, is indicated to provide a rapid, pain-free, and noninvasive imaging evaluation for earlier disease detection.
Legal
Montana passes OD scope expansion for laser procedures
Set to take effect on July 1, H.B. 218 permits optometrists to perform in-office laser and surgical procedures across the state.
Business
CORE Director Dr. Lyndon Jones to step down amid scope expansion
CORE announces integration plans into the Waterloo Eye Institute and the creation of a steering committee as it looks to expand into research of the vision system and beyond.
Research
New technology targets photoreceptor cells to create a novel color
Oz prototype system allows for perception of “olo,” a blue-green color not visible in natural vision.
Research
Smoking among factors linked to retinal vessel trait changes
Association with larger retinal arteriolar and venular size may have important implications for ocular health.
Products
FDA grants expanded clearance for Luminopia binocular amblyopia therapy
Updated label for the VR-based digital platform expands indications to include pediatric patients aged 8 to 12.
Pipeline
Palatin reports symptom resolution phase 3 data for DED eye drop
Responder analyses indicate PL9643 achieved statistically significant complete symptom clearing across multiple endpoints starting at 2 weeks and increasing to week 12.
Business
Topcon names former Genentech exec as chief medical officer
Daniela Ferrara, MD, PhD’s role involves establishing retinal imaging as a first-line tool for both eyecare and the screening and management of complex systemic diseases.
Products
Nordic Pharma launches authorized generic of Maxitrol
Company to introduce prescription-based drop in partnership with Harrow; indication includes treating and relieving bacterial eye infections.
Research
Study connects HDL levels to AMD development
Key finding: A U-shaped relationship between low and high HDL and increased risk of AMD.
Research
SpyGlass Pharma reports positive 18-month data on glaucoma sustained delivery system
Presented at ASCRS, new findings show promising visual outcomes and IOP lowering following sustained-release delivery of bimatoprost.
Products
Alcon debuts new digital platform for clinics and surgery centers
Designed for use within the Alcon Vision Suite, this cloud-based platform connects clinics’ patient and surgery data to a surgery center.
Research
Clinical outcomes support JJV's violet-filtering IOL for glaucoma
New research on the Tecnis Symfony OptiBlue IOL shows promising visual outcomes just one week after implantation post-cataract surgery.
Products
Alcon launches UNITY vitreoretinal and cataract surgery systems
Debuting at ASCRS, the UNITY Vitreoretinal Cataract and Cataract stand-alone systems expand the Alcon Vision Suite of surgical technologies.
Pipeline
Long-term data finds acoltremon 0.003% increases tear production in DED
Presented at ASCRS, phase 3 COMET-4 results show AR-15512 provides a rapid onset and sustained improvement over 12 months.
Products
Sight Sciences debuts OMNI Edge Surgical System
Launching during ASCRS, this new hand-held and single-use MIGS device features the company’s patented, higher-capacity viscoelastic delivery TruSync technology.
Research
Safety and efficacy data supports Vista 1-Step vitrectomy probe
A total of 86% of pseudophakic patients reported a complete resolution of symptoms by postop month 3 following limited vitreous removal procedure.
Products
B+L's enVista IOLs return to market after voluntary recall
Company announces conclusion of investigation into reported cases of TASS involving the enVista IOL product line.
Business